Name | LSP-249 |
---|
Description | LSP-249 (example 35), extracted from patent WO2016011209A1, is a plasma kallikrein inhibitor under the study for angioedema, with an EC50 less than 100 nM in cell[1]. |
---|---|
Related Catalog | |
Target |
EC50:< 100 nM (kallikrein in cell)[1]. |
References |
[1]. Andrew Mcdonald, et al. Therapeutic inhibitory compounds. Patent. WO2016011209A1. |
Molecular Formula | C24H22ClN5O |
---|---|
Molecular Weight | 431.92 |
Storage condition | -20°C |